Combating Rheumatoid Arthritis with Berberine and Curcumin: A Review of Natural Therapeutics
DOI:
https://doi.org/10.63682/jns.v14i20S.5722Keywords:
rheumatoid arthritis (RA), Nanostructured lipid carriers (NLCs)Abstract
Rheumatoid arthritis (RA) is a long-term inflammatory disease that causes synovial joint inflammation, which causes pain, stiffness, and gradual joint destruction. In addition to having a major effect on quality of life, the illness may result in systemic problems. The goal of current treatment approaches, which include biologics, corticosteroids, disease-modifying antirheumatic medications (DMARDs), and nonsteroidal anti-inflammatory medicines (NSAIDs), is to manage symptoms and halt the course of the disease. These treatments, however, frequently have problems like poor effectiveness, systemic side effects, and exorbitant expenses. Advanced, tailored medication delivery methods like nanocarriers are necessary because managing RA is made more difficult by poor patient adherence and limited targeting of inflammatory areas.
Berberine and curcumin are bioactive natural compounds with significant therapeutic potential, particularly in managing inflammatory and autoimmune conditions like rheumatoid arthritis (RA). Berberine exhibits potent anti-inflammatory, immunomodulatory, and antioxidant properties, effectively suppressing pro-inflammatory cytokines and oxidative stress Curcumin, a polyphenol derived from turmeric, also demonstrates strong anti-inflammatory and antioxidant effects, inhibiting key molecular pathways involved in RA pathogenesis, such as NF-κB activation. Despite their promising pharmacological profiles, both compounds face challenges like poor water solubility, low bioavailability, and rapid metabolism. Advanced drug delivery systems, such as nanostructured lipid carriers, offer a solution to enhance their therapeutic efficacy and clinical applicability.
Nanostructured lipid carriers (NLCs) are advanced drug delivery systems offering numerous advantages for therapeutic applications. Their unique structure, combining solid and liquid lipids, enhances drug solubility, stability, and bioavailability. NLCs enable controlled and sustained drug release, reducing dosing frequency and improving patient compliance. They can protect sensitive drugs like berberine and curcumin from degradation, extending their shelf life. Additionally, NLCs can be functionalized for targeted delivery, increasing drug accumulation at inflamed joints in conditions like rheumatoid arthritis while minimizing systemic side effects. Their biocompatibility and scalability make NLCs a promising platform for improving the clinical efficacy of challenging therapeutic agents.
Berberine and curcumin exhibit remarkable anti-inflammatory and antioxidant properties, making them promising candidates for managing rheumatoid arthritis (RA). However, their clinical potential is limited by poor solubility and bioavailability. Nanostructured lipid carriers (NLCs) address these limitations by enhancing drug stability, targeted delivery, and controlled release. Preclinical studies demonstrate improved therapeutic efficacy of NLC formulations in RA models, though clinical translation remains limited. Future research should focus on optimizing NLC designs for enhanced targeting, scalability, and regulatory compliance. Combining these carriers with advanced therapeutic strategies offers a pathway to more effective and patient-friendly RA treatments, bridging lab discoveries to clinical practice
Downloads
Metrics
References
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research. 2018;6(1):15.
Lin Y-J, Anzaghe M, Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis. Cells. 2020;9(4):880.
Esfahani K, Elkrief A, Calabrese C, Lapointe R, Hudson M, Routy B, et al. Moving towards personalized treatments of immune-related adverse events. Nature reviews Clinical oncology. 2020;17(8):504-15.
Alshawwa SZ, Kassem AA, Farid RM, Mostafa SK, Labib GS. Nanocarrier drug delivery systems: characterization, limitations, future perspectives and implementation of artificial intelligence. Pharmaceutics. 2022;14(4):883.
Teixeira M, Carbone C, Souto E. Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble/poorly permeable drug delivery. Progress in lipid research. 2017;68:1-11.
Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, et al. Where is nano today and where is it headed? A review of nanomedicine and the dilemma of nanotoxicology. ACS nano. 2022;16(7):9994-10041.
Haider M, Abdin SM, Kamal L, Orive G. Nanostructured lipid carriers for delivery of chemotherapeutics: A review. Pharmaceutics. 2020;12(3):288.
Garg NK, Tyagi RK, Singh B, Sharma G, Nirbhavane P, Kushwah V, et al. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. International journal of pharmaceutics. 2016;499(1-2):301-20.
Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release. European Journal of Pharmaceutics and Biopharmaceutics. 2018;133:285-308.
Rizwanullah M, Ahmad J, Amin S. Nanostructured lipid carriers: a novel platform for chemotherapeutics. Current drug delivery. 2016;13(1):4-26.
Bhalani DV, Nutan B, Kumar A, Singh Chandel AK. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines. 2022;10(9):2055.
Mehta M, Bui TA, Yang X, Aksoy Y, Goldys EM, Deng W. Lipid-based nanoparticles for drug/gene delivery: an overview of the production techniques and difficulties encountered in their industrial development. ACS Materials Au. 2023;3(6):600-19.
Amoabediny G, Haghiralsadat F, Naderinezhad S, Helder MN, Akhoundi Kharanaghi E, Mohammadnejad Arough J, et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review. International Journal of Polymeric Materials and Polymeric Biomaterials. 2018;67(6):383-400.
Ganesan P, Narayanasamy D. Lipid nanoparticles: Different preparation techniques, characterization, hurdles, and strategies for the production of solid lipid nanoparticles and nanostructured lipid carriers for oral drug delivery. Sustainable Chemistry and Pharmacy. 2017;6:37-56.
Duong V-A, Nguyen T-T-L, Maeng H-J. Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method. Molecules. 2020;25(20):4781.
Chuang S-Y, Lin C-H, Huang T-H, Fang J-Y. Lipid-based nanoparticles as a potential delivery approach in the treatment of rheumatoid arthritis. Nanomaterials. 2018;8(1):42.
Duan Y, Dhar A, Patel C, Khimani M, Neogi S, Sharma P, et al. A brief review on solid lipid nanoparticles: Part and parcel of contemporary drug delivery systems. RSC advances. 2020;10(45):26777-91.
Moballegh Nasery M, Abadi B, Poormoghadam D, Zarrabi A, Keyhanvar P, Khanbabaei H, et al. Curcumin delivery mediated by bio-based nanoparticles: a review. Molecules. 2020;25(3):689.
Mu H, Holm R. Solid lipid nanocarriers in drug delivery: Characterization and design. Expert opinion on drug delivery. 2018;15(8):771-85.
Alam T, Pandit J, Vohora D, Aqil M, Ali A, Sultana Y. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert opinion on drug delivery. 2015;12(2):181-94.
Souto EB, Baldim I, Oliveira WP, Rao R, Yadav N, Gama FM, et al. SLN and NLC for topical, dermal, and transdermal drug delivery. Expert opinion on drug delivery. 2020;17(3):357-77.
Permana AD, Tekko IA, McCrudden MT, Anjani QK, Ramadon D, McCarthy HO, et al. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis. Journal of controlled release. 2019;316:34-52.
Pramanik S, Mohanto S, Manne R, Rajendran RR, Deepak A, Edapully SJ, et al. Nanoparticle-based drug delivery system: the magic bullet for the treatment of chronic pulmonary diseases. Molecular Pharmaceutics. 2021;18(10):3671-718.
Cunha S, Forbes B, Sousa Lobo JM, Silva AC. Improving drug delivery for Alzheimer’s disease through nose-to-brain delivery using nanoemulsions, nanostructured lipid carriers (NLC) and in situ hydrogels. International journal of nanomedicine. 2021:4373-90.
Salem LH, El-Feky GS, Fahmy RH, El Gazayerly ON, Abdelbary A. Coated lipidic nanoparticles as a new strategy for enhancing nose-to-brain delivery of a hydrophilic drug molecule. Journal of Pharmaceutical Sciences. 2020;109(7):2237-51.
Barani M, Sangiovanni E, Angarano M, Rajizadeh MA, Mehrabani M, Piazza S, et al. Phytosomes as innovative delivery systems for phytochemicals: A comprehensive review of literature. International journal of nanomedicine. 2021:6983-7022.
Rosiaux Y, Jannin V, Hughes S, Marchaud D. Solid lipid excipients as matrix agents for sustained drug delivery. Excipient Applications in Formulation Design and Drug Delivery. 2015:237-71.
Chauhan I, Yasir M, Verma M, Singh AP. Nanostructured lipid carriers: A groundbreaking approach for transdermal drug delivery. Advanced pharmaceutical bulletin. 2020;10(2):150.
Lee D, Minko T. Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier. Pharmaceutics. 2021;13(12):2049.
Subramaniam B, Siddik ZH, Nagoor NH. Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations. Journal of nanoparticle research. 2020;22:1-29.
Falsafi SR, Rostamabadi H, Assadpour E, Jafari SM. Morphology and microstructural analysis of bioactive-loaded micro/nanocarriers via microscopy techniques; CLSM/SEM/TEM/AFM. Advances in Colloid and Interface Science. 2020;280:102166.
Formica ML, Real DA, Picchio ML, Catlin E, Donnelly RF, Paredes AJ. On a highway to the brain: A review on nose-to-brain drug delivery using nanoparticles. Applied Materials Today. 2022;29:101631.
Keservani RK, Sharma AK, Kesharwani RK. Nanocarriers for brain targeting: principles and applications: CRC Press; 2019.
Shah NV, Seth AK, Balaraman R, Aundhia CJ, Maheshwari RA, Parmar GR. Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study. Journal of advanced research. 2016;7(3):423-34.
Gupta R, Chen Y, Xie H. In vitro dissolution considerations associated with nano drug delivery systems. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2021;13(6):e1732.
Kim Y, Park EJ, Kim TW, Na DH. Recent progress in drug release testing methods of biopolymeric particulate system. Pharmaceutics. 2021;13(8):1313.
Mircioiu C, Voicu V, Anuta V, Tudose A, Celia C, Paolino D, et al. Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics. 2019;11(3):140.
Qu F, Geng R, Liu Y, Zhu J. Advanced nanocarrier-and microneedle-based transdermal drug delivery strategies for skin diseases treatment. Theranostics. 2022;12(7):3372.
Chavda VP, Patel AB, Mistry KJ, Suthar SF, Wu Z-X, Chen Z-S, et al. Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges. Frontiers in oncology. 2022;12:867655.
Siafaka PI, Üstündağ Okur N, Karavas E, Bikiaris DN. Surface modified multifunctional and stimuli responsive nanoparticles for drug targeting: current status and uses. International journal of molecular sciences. 2016;17(9):1440.
Bakshi H, Nagpal M, Singh M, Dhingra GA, Aggarwal G. Treatment of psoriasis: a comprehensive review of entire therapies. Current drug safety. 2020;15(2):82-104.
Xu Y, Zhao M, Cao J, Fang T, Zhang J, Zhen Y, et al. Applications and recent advances in transdermal drug delivery systems for the treatment of rheumatoid arthritis. Acta Pharmaceutica Sinica B. 2023;13(11):4417-41.
Ahamad N, Kar A, Mehta S, Dewani M, Ravichandran V, Bhardwaj P, et al. Immunomodulatory nanosystems for treating inflammatory diseases. Biomaterials. 2021;274:120875.
Cao F, Gui S-Y, Gao X, Zhang W, Fu Z-Y, Tao L-M, et al. Research progress of natural product-based nanomaterials for the treatment of inflammation-related diseases. Materials & Design. 2022;218:110686.
Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin formulations for better bioavailability: what we learned from clinical trials thus far? ACS omega. 2023;8(12):10713-46.
Waghule T, Gorantla S, Rapalli VK, Shah P, Dubey SK, Saha RN, et al. Emerging trends in topical delivery of curcumin through lipid nanocarriers: effectiveness in skin disorders. Aaps Pharmscitech. 2020;21:1-12.
Kesharwani D, Paliwal R, Satapathy T, Paul SD. Rheumatiod arthritis: an updated overview of latest therapy and drug delivery. Journal of pharmacopuncture. 2019;22(4):210.
Xu X-Y, Meng X, Li S, Gan R-Y, Li Y, Li H-B. Bioactivity, health benefits, and related molecular mechanisms of curcumin: Current progress, challenges, and perspectives. Nutrients. 2018;10(10):1553.
Zhu Z, Li J, Ruan G, Wang G, Huang C, Ding C. Investigational drugs for the treatment of osteoarthritis, an update on recent developments. Expert opinion on investigational drugs. 2018;27(11):881-900.
Nguyen T-T-L, Duong V-A, Maeng H-J. Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability. Pharmaceutics. 2021;13(7):1103.
Singh S, Pathak N, Fatima E, Negi AS. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine. European journal of medicinal chemistry. 2021;226:113839.
Sahoo DK, Heilmann RM, Paital B, Patel A, Yadav VK, Wong D, et al. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. Frontiers in endocrinology. 2023;14:1217165.
Jantan I, Ahmad W, Bukhari SNA. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Frontiers in plant science. 2015;6:655.
Sainz-Urruela C, Vera-López S, San Andrés MP, Díez-Pascual AM. Graphene-based sensors for the detection of bioactive compounds: A review. International Journal of Molecular Sciences. 2021;22(7):3316.
Tagde P, Tagde P, Islam F, Tagde S, Shah M, Hussain ZD, et al. The multifaceted role of curcumin in advanced nanocurcumin form in the treatment and management of chronic disorders. Molecules. 2021;26(23):7109.
Patel SS, Acharya A, Ray R, Agrawal R, Raghuwanshi R, Jain P. Cellular and molecular mechanisms of curcumin in prevention and treatment of disease. Critical reviews in food science and nutrition. 2020;60(6):887-939.
Huang T, Liu Y, Zhang C. Pharmacokinetics and bioavailability enhancement of baicalin: a review. European Journal of Drug Metabolism and Pharmacokinetics. 2019;44:159-68.
Fuloria S, Mehta J, Chandel A, Sekar M, Rani NNIM, Begum MY, et al. A comprehensive review on the therapeutic potential of Curcuma longa Linn. in relation to its major active constituent curcumin. Frontiers in Pharmacology. 2022;13:820806.
Upadhyay S, Dixit M. Role of polyphenols and other phytochemicals on molecular signaling. Oxidative medicine and cellular longevity. 2015;2015(1):504253.
Beloqui A, Solinís MÁ, Rodríguez-Gascón A, Almeida AJ, Préat V. Nanostructured lipid carriers: Promising drug delivery systems for future clinics. Nanomedicine: Nanotechnology, biology and medicine. 2016;12(1):143-61.
Rodan K, Fields K, Majewski G, Falla T. Skincare bootcamp: the evolving role of skincare. Plastic and Reconstructive Surgery–Global Open. 2016;4(12S):e1152.
Halla N, Fernandes IP, Heleno SA, Costa P, Boucherit-Otmani Z, Boucherit K, et al. Cosmetics preservation: a review on present strategies. Molecules. 2018;23(7):1571.
Mannekote JK, Kailas SV, Venkatesh K, Kathyayini N. Environmentally friendly functional fluids from renewable and sustainable sources-A review. Renewable and sustainable energy reviews. 2018;81:1787-801.
De Corato U. Improving the shelf-life and quality of fresh and minimally-processed fruits and vegetables for a modern food industry: A comprehensive critical review from the traditional technologies into the most promising advancements. Critical Reviews in Food Science and Nutrition. 2020;60(6):940-75.
Pereira L. Seaweeds as source of bioactive substances and skin care therapy—cosmeceuticals, algotheraphy, and thalassotherapy. Cosmetics. 2018;5(4):68.
Rajmohan K, Chandrasekaran R, Varjani S. A review on occurrence of pesticides in environment and current technologies for their remediation and management. Indian journal of microbiology. 2020;60(2):125-38.
Kanwar R, Rathee J, Salunke DB, Mehta SK. Green nanotechnology-driven drug delivery assemblies. ACS omega. 2019;4(5):8804-15.
Ashfaq R, Rasul A, Asghar S, Kovács A, Berkó S, Budai-Szűcs M. Lipid nanoparticles: an effective tool to improve the bioavailability of nutraceuticals. International Journal of Molecular Sciences. 2023;24(21):15764.
Chavda VP, Nalla LV, Balar P, Bezbaruah R, Apostolopoulos V, Singla RK, et al. Advanced phytochemical-based nanocarrier systems for the treatment of breast cancer. Cancers. 2023;15(4):1023.
Bruni N, Della Pepa C, Oliaro-Bosso S, Pessione E, Gastaldi D, Dosio F. Cannabinoid delivery systems for pain and inflammation treatment. Molecules. 2018;23(10):2478.
Khan AR, Yang X, Fu M, Zhai G. Recent progress of drug nanoformulations targeting to brain. Journal of Controlled Release. 2018;291:37-64.
Kumar G, Virmani T, Sharma A, Pathak K. Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers. Pharmaceutics. 2023;15(3):889.
Abdel-Mageed HM, AbuelEzz NZ, Radwan RA, Mohamed SA. Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities. Journal of microencapsulation. 2021;38(6):414-36.
Gupta V, Mohapatra S, Mishra H, Farooq U, Kumar K, Ansari MJ, et al. Nanotechnology in cosmetics and cosmeceuticals—a review of latest advancements. Gels. 2022;8(3):173.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
